Form 4: Treace Medical Concepts CEO John T. Treace Reports Stock Disposals to Cover Tax Obligations
SEC Form 4
CEO John T. Treace of Treace Medical Concepts, Inc. reports disposing of shares to cover tax obligations related to restricted stock units.
Summary
- On March 8, 2024, John T. Treace, CEO of Treace Medical Concepts, Inc., disposed of 2,064 shares of common stock to cover tax obligations.
- On March 10, 2024, Mr. Treace disposed of 5,021 shares of common stock for the same reason.
- Following these transactions, Mr. Treace directly owns 5,793,095 shares of common stock.
- Mr. Treace also has indirect ownership of shares through his spouse and trusts, but disclaims beneficial ownership of these shares.
- The report was filed on March 12, 2024.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions related to tax obligations. It doesn't indicate positive or negative sentiment.
Industry Context
This is a routine filing related to executive stock transactions and is common for publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 03/08/2024 | Disposal of 2,064 shares of common stock. |
| 03/10/2024 | Disposal of 5,021 shares of common stock. |
| 03/12/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.